Evaluation of the Therapeutic Efficacy of Different Levothyroxine Preparations in the Treatment of Human Thyroid Disease

Thyroid

Volumn 13, Issue 12, 2003, Pages 1127-1132

  Klein, Irwin ^a,b   Danzi, Sara ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVO T; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; NOVOTHYROX; THYRO TABS; THYROID HORMONE; THYROTROPIN; UNITHROID;

ATHEROSCLEROSIS; BIOEQUIVALENCE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SOLUBILITY; EUTHYROIDISM; FOOD AND DRUG ADMINISTRATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; PRIORITY JOURNAL; REVIEW; THYROID DISEASE;

EID: 0346102452     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250360731523     Document Type: Review

References (35)

1. Levey GS, Klein I 1998 Disorders of the thyroid. In: Stein JH, (ed). Internal Medicine, 5th ed. Mosby, St. Louis, pp 1323-1349.
2. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489-499.
3. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostine PB 1994 Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-1252.
4. Klein I, Ojamaa K 2001 Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509.
5. Carr D, McLeod DT, Parry G, Thornes HM 1988 Fine adjustment of thyroxine replacement dosage: Comparison of thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf) 28:325-333.
6. LeBoff MS, Kaplan MM, Silva JE, Larsen PR 1982 Bioavailability of thyroid hormones from oral replacement preparations. Metabolism 31:900-905.
7. Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, Bubp JL, Greenspan FS 1997 Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA 277:1205-1213.
8. Anderson GW, Mariash C, Oppenheimer J 2000 Molecular actions of thyroid hormones. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 174-195.
9. Brent G 1994 The molecular basis of thyroid hormone action. N Engl J Med 331:847-853.
10. Klein I, Levey GS 1984 Unusual manifestations of hypothyroidism. Arch Intern Med 144:123-128.
11. Brent G, Larsen PR 2000 Treatment of hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 853-860.
12. Turnbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA 1977 The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol (Oxf) 7:481-493.
13. Singer DA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G 1995 Treatment guidelines for patients with hyperthyrodism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 273:808-812.
14. Demers LM, Spencer CA 2003 Laboratory medicine practice guidelines: Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3-126.
15. Klein I, Becker D, Levey GS 1994 Treatment of hyperthyroid disease. Ann Intern Med 121:281-288.
16. Sawin CT 1985 Hypothyroidism. Med Clin North Am 69:989-1004.
17. Leonard JL, Koehrle J 2000 Intracellular pathways of iodothyronine metaoblism. In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 136-175.
18. Ross DS 2001 Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease. Endocrinol Metab Clin North Am 30:245-264.
19. Andersen S, Pedersen KM, Bruun NH, Laurberg P 2002 Narrow individual variations in serum T(4) and T(3) in normal subjects: A clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068-1072.
20. Mandel SJ, Larsen PR, Seely EW, Brent GA 1990 Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N Engl J Med 323:91-96.
21. Biondi B, Palmieri E, Lombardi G, Fazio S 2002 Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 137:904-914.
22. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado thyroid disease prevalence study. Arch Intern Med 160:526-530.
23. Klein I 2001 Clinical, metabolic and organ-specific indices of thyroid function. Endocrinol Metab Clin North Am 30:415-427.
24. Crowley WF Jr, Ridgway EC, Bough EW, Francis GS, Daniels GH, Kourides IA, Myers GS, Maloof F 1997 Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med 296:1-6.
25. Klein I, Trzepacz P, Roberts M, Levey GS 1988 Symptom rating scale for assessing hyperthyroidism. Arch Intern Med 148:387-390.
26. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Guidance for Industry: Levothyroxine Sodium Tablets-In vivo pharmacokinetic and bioavailabity studies and in vitro dissolution testing, December 2000.
27. Abbott Laboratories. Briefing Document to the FDA Advisory Committee for Pharmaceutical Science, March 2003.
28. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM 2000 Subclinical hypothryoidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam study. Ann Intern Med 132:270-278.
29. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Levoxyl Application No.: 21-301, 5/25/01.
30. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Synthroid Application No. 21-402, 7/24/02.
31. Hays MT 1988 Thyroid hormone and the gut. Endocr Res 14:203-224.
32. Blouin RA, Clifton GD, Adams MA, Foster TS, Flueck J 1989 Biopharmaceutical comparison of two levothyroxine sodium products. Clin Pharm 8:588-592.
33. Levothryoxine Sodium Tablets in United States Pharmacopeia, USP26-NF21, 2002.
34. Danzi S, Ojamaa K, Klein I 2003 Triiodothyronine-mediated myosin heavy chain gene transcription in the heart. Am J Physiol 284:H2255-H2262.
35. Sellin JH and Vassilopoulou-Sellin R 2000 The gastrointestinal tract and liver in hypothyroidism: In: Braverman LE, Utiger RD, eds. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 795-802.